The infant presenting with an episode of apnoea probably represents a heterogenous group of clinical disorders. A diagnosis of 'Near miss sudden infant death syndrome' is usually made after a thorough evaluation fails to reveal the cause of an apnoeic episode. Infants considered to be at risk for further episodes may be placed on apnoea monitors or may be treated pharmacologically with caffeine or theophylline. 1 These drugs are potent central nervous system (CNS) stimulants and when used in high doses may produce convulsions in infants. 2 Therapeutic doses of methylxanthines may also precipitate convulsions in infants with latent seizure disorders not detected by routine electroencephalogram (EEG). This possibility was documented in two infants who presented with episodes of apnoea and forms the basis of this report.
Experience in these infants suggests that there is a subgroup of infants diagnosed as near miss sudden infant death syndrome who have apnoea associated with seizures. Seizure threshold may be lowered by CNS stimulants like the methylxanthines and result in clinical seizures. The neuroleptic malignant syndrome is the most serious yet least known complication of neuroleptic therapy, characterised by muscular rigidity, hyperthermia, altered consciousness, and autonomic dysfunction. It was first described in 19601 and up to 1984 over 80 cases had been reported, mainly in adult, medical, and psychiatric spheres. We report a case of the neuroleptic malignant syndrome occurring in childhood.
Case report
The case was an 8 year old boy, who had presented at the age of 10 months with microcephaly and mental handicap considered to be due to maternal treatment with phenytoin during pregnancy. He had attended a special school and was not being treated with drugs but had been given thioridazine in 1979 for nine days. There was no family history of anaesthetic problems. He had had a febrile illness before admission and had been prescribed 5 mg prochlorperazine six hourly because of vomiting. After three days of treatment he had sudden onset of extreme agitation, opisthotonos, and episodic dystonic movements. This persisted and he was admitted to hospital.
On admission he had a fever of 38°C and was dehydrated. His remarkable posture and involuntary movements were unabated (Figure) , yet he was able to recognise his parents. Except for transient benefit from sedation he remained in this state for the following eight weeks, also showing widespread evidence of autonomic dysfunction-that is, periodic rises *of temperature to 40°C, profuse diaphoresis, apex rate 100 to 140 per minute, respiratory rate 45 to 50 beats per minute, and blood pressure 90/50 to 120/70. Investigations showed a white blood cell count of 13 000 and normal result of blood count, tests on cerebrospinal fluid, viral studies, electroencephalography, and computed tomography. He had raised liver and muscle enzymes: aspartate aminotransferase 662 (normal 8-40) iu/l, alanine aminotransferase 226 (normal 5-35) iu/l, and creatine phosphokinase 5243 (normal 0-130) iu/l. Initially, this was thought to be a prolonged drug induced dystonia, but the condition was unresponsive to the usual therapeutic regimens. It was noteworthy that the only drug that seemed to be of benefit in sedating the patient was thioridazine, itself a phenothiazine. After an interval of
